A Phase 2 Randomized Controlled Trial of Personalized Peptide Vaccine Immunotherapy with Low-dose Dexamethasone Versus Dexamethasone Alone in Chemotherapy-naive Castration-resistant Prostate Cancer

Low Dose ◽

Controlled Trial ◽

Peptide Vaccine ◽

Phase 2 ◽

Randomized Controlled ◽

Castration Resistant ◽

Personalized Peptide Vaccine

Re: Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

European Urology ◽

10.1016/j.eururo.2010.06.020 ◽

2010 ◽

Vol 58 (3) ◽

pp. 466 ◽

Cited By ~ 1

Author(s):

David S. Finley ◽

Frederic Pouliot ◽

Allan Pantuck

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Survival Analysis ◽

Controlled Trial ◽

Randomized Controlled ◽

Castration Resistant ◽

Overall Survival Analysis ◽

Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer

Yearbook of Oncology ◽

10.1016/s1040-1741(10)79581-6 ◽

2011 ◽

Vol 2011 ◽

pp. 110-111

Author(s):

C.A. Lawton

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Survival Analysis ◽

Controlled Trial ◽

Randomized Controlled ◽

Castration Resistant ◽

Overall Survival Analysis ◽

Decreased biochemical progression in patients with castration‑resistant prostate cancer using a novel mefenamic acid anti‑inflammatory therapy: A randomized controlled trial

Oncology Letters ◽

10.3892/ol.2020.11509 ◽

2020 ◽

Author(s):

Jos� Guzman‑Esquivel ◽

Martha Mendoza‑Hernandez ◽

Daniel Tiburcio‑Jimenez ◽

Oscar Avila‑Zamora ◽

Josuel Delgado‑Enciso ◽

...

Keyword(s):

Prostate Cancer ◽

Mefenamic Acid ◽

Controlled Trial ◽

Randomized Controlled ◽

Castration Resistant ◽

Biochemical Progression ◽

Anti Inflammatory

Abiraterone acetate plus LHRH therapy versus abiraterone acetate while sparing LHRH therapy in patients with progressive, metastatic and chemotherapy-naïve, castration-resistant prostate cancer (SPARE): study protocol for a randomized controlled trial

Trials ◽

10.1186/s13063-017-2195-x ◽

2017 ◽

Vol 18 (1) ◽

Cited By ~ 5

Author(s):

Carsten-Henning Ohlmann ◽

Michelle Jäschke ◽

Peter Jaehnig ◽

Susane Krege ◽

Jürgen Gschwend ◽

...

Keyword(s):

Prostate Cancer ◽

Study Protocol ◽

Controlled Trial ◽

Abiraterone Acetate ◽

Randomized Controlled ◽

Castration Resistant ◽

Lhrh Therapy

A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate (EMP) versus standard dose EMP in patients with castration resistant prostate cancer

Cancer Immunology Immunotherapy ◽

10.1007/s00262-010-0822-4 ◽

2010 ◽

Vol 59 (7) ◽

pp. 1001-1009 ◽

Cited By ~ 78

Author(s):

Masanori Noguchi ◽

Tatsuyuki Kakuma ◽

Hirotsugu Uemura ◽

Yasutomo Nasu ◽

Hiromi Kumon ◽

...

Keyword(s):

Prostate Cancer ◽

Low Dose ◽

Phase Ii Trial ◽

Standard Dose ◽

Peptide Vaccine ◽

Estramustine Phosphate ◽

Castration Resistant ◽

Randomized Phase Ii ◽

Personalized Peptide Vaccine

7002 Further analysis of a Phase II randomized controlled trial (RCT) of a poxviral-based PSA targeted immunotherapy in metastatic castration-resistant prostate cancer (mCRPC)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)71380-1 ◽

2009 ◽

Vol 7 (2) ◽

pp. 406 ◽

Cited By ~ 1

Author(s):

W.R. Godfrey ◽

B.A. Blumenstein ◽

T.J. Schuetz ◽

L.M. Glode ◽

D.L. Bilhartz ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Controlled Trial ◽

Randomized Controlled ◽

Castration Resistant ◽

Revealing Prognostic Value of Skeletal-Related Parameters in Metastatic Castration-Resistant Prostate Cancer on Overall Survival: A Systematic Review and Meta-Analysis of Randomized Controlled Trial

Frontiers in Oncology ◽

10.3389/fonc.2020.586192 ◽

2020 ◽

Vol 10 ◽

Author(s):

Tongyu Tong ◽

Hanqi Lei ◽

Yupeng Guan ◽

Xiangwei Yang ◽

Guolong Liao ◽

...

Keyword(s):

Prostate Cancer ◽

Systematic Review ◽

Overall Survival ◽

Prognostic Value ◽

Controlled Trial ◽

Meta Analysis ◽

Randomized Controlled ◽

Castration Resistant

Feasibility study of a randomized controlled trial comparing docetaxel chemotherapy and androgen deprivation therapy with sequential prostatic biopsies from patients with advanced non–castration-resistant prostate cancer

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2015.05.012 ◽

2015 ◽

Vol 33 (8) ◽

pp. 337.e1-337.e6 ◽

Cited By ~ 4

Author(s):

Prabhakar Rajan ◽

John A. Frew ◽

James M. Wilson ◽

Ashraf S.T. Azzabi ◽

Rhona M. McMenemin ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Deprivation Therapy ◽

Feasibility Study ◽

Controlled Trial ◽

Androgen Deprivation ◽

Randomized Controlled ◽

Castration Resistant ◽

Docetaxel Chemotherapy

Re: Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

European Urology ◽

10.1016/j.eururo.2010.07.016 ◽

2010 ◽

Vol 58 (4) ◽

pp. 632-633 ◽

Cited By ~ 1

Author(s):

Ellen A.M. Schenk

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Survival Analysis ◽

Controlled Trial ◽

Randomized Controlled ◽

Castration Resistant ◽

Overall Survival Analysis ◽

Editorial Comment to Comparison of disease‐specific quality of life in prostate cancer patients treated with low‐dose‐rate brachytherapy: A randomized controlled trial of silodosin versus naftopidil

International Journal of Urology ◽

10.1111/iju.14690 ◽

2021 ◽

Author(s):

Yoshifumi Kadono

Keyword(s):

Quality Of Life ◽

Prostate Cancer ◽

Low Dose ◽

Controlled Trial ◽

Low Dose Rate ◽

Randomized Controlled ◽

Disease Specific ◽

Low Dose Rate Brachytherapy